For: | Klenzak S, Danelisen I, Brannan GD, Holland MA, van Tilburg MA. Management of gastroesophageal reflux disease: Patient and physician communication challenges and shared decision making. World J Clin Cases 2018; 6(15): 892-900 [PMID: 30568943 DOI: 10.12998/wjcc.v6.i15.892] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v6/i15/892.htm |
Number | Citing Articles |
1 |
Ahmed Al-Marhabi, Ahmed Hashem, Bader Faiyaz Zuberi, Charles Onyekwere, Imran Lodhi, Mohamed Mounir, Saad Alkhowaiter, Sameer Al Awadhi, Vasudevan G. Naidoo, Yasser Hamada. The views of African and Middle Eastern Gastroenterologists on the management of mild-to-moderate, non-erosive gastro-esophageal reflux disease (GERD). Expert Review of Gastroenterology & Hepatology 2022; 16(3): 217 doi: 10.1080/17474124.2022.2043744
|
2 |
Tariq M Shaqran, Mustafa M Ismaeel, Aljoharh Abdulaziz Alnuaman, Fatimah A Al Ahmad, Ghadeer A Albalawi, Jori N Almubarak, Rakan S AlHarbi, Rayan S Alaqidi , Yaqin A AlAli, Khaled S Alfawaz, Abdulrhman A Daghriri. Epidemiology, Causes, and Management of Gastro-esophageal Reflux Disease: A Systematic Review. Cureus 2023; doi: 10.7759/cureus.47420
|
3 |
Michelle J. Gould, Chantelle Lin, Catharine M. Walsh. A Systematic Assessment of the Quality of Smartphone Applications for Gastroesophageal Reflux Disease. Gastro Hep Advances 2023; 2(5): 733 doi: 10.1016/j.gastha.2023.03.001
|
4 |
Bindong Dai, Chunfeng Xiao, Yufei Wang, Tao Li, Yanping Duan, Yinan Jiang, Lili Shi, Xia Hong, Wenqi Geng, Jiaojiao Hu, Jinya Cao, Jing Wei. Development and psychometric validation of the hospitalized patients’ expectations for treatment scale-clinician version. Frontiers in Psychiatry 2024; 14 doi: 10.3389/fpsyt.2023.1325013
|
5 |
Kairu Zhou, Li Chen, Min Li. The Impact of Medical Risk Perception on Patient Satisfaction: The Moderating Role of Shared Decision-Making. Risk Management and Healthcare Policy 2024; : 2981 doi: 10.2147/RMHP.S482908
|
6 |
Roberta Salaroli, Domenico Ventrella, Chiara Bernardini, Alberto Elmi, Augusta Zannoni, Maria Laura Bacci, Monica Forni, Fiorella Calanni, Antonella Ferrieri, Fabio Baldi. <p>Barrier Effect of a New Topical Agent on Damaged Esophageal Mucosa: Experimental Study on an ex vivo Swine Model</p>. Clinical and Experimental Gastroenterology 2020; : 569 doi: 10.2147/CEG.S269568
|
7 |
Jacques A. Greenberg, Federico Palacardo, Rodrigo C.L. Edelmuth, Caitlin E. Egan, Yeon Joo Lee, Felice H. Schnoll-Sussman, Philip O. Katz, Brendan M. Finnerty, Thomas J. Fahey, Rasa Zarnegar. Comparative Outcomes of Anti-Reflux Surgery in Obese Patients with Gastroesophageal Reflux Disease1. Journal of Gastrointestinal Surgery 2023; 27(3): 502 doi: 10.1007/s11605-022-05455-1
|
8 |
László Herszényi. Reflux Symptoms – Functional and Structural Diseases: The Approach from the General Practitioner. Digestive Diseases 2021; 39(6): 585 doi: 10.1159/000515116
|
9 |
Afrin N. Kamal, C. Jason Wang, George Triadafilopoulos, John O. Clarke. Healthcare Disparities in Gastroesophageal Reflux Disease for Hispanic and Latino Americans: A Solution-Oriented Approach for Improvement. American Journal of Gastroenterology 2023; 118(2): 193 doi: 10.14309/ajg.0000000000001976
|
10 |
Fahad Alzahrani, Yousef Al Turki. Knowledge and practice of family medicine and internal medicine residents toward the management of gastroesophageal reflux disease in Riyadh, Saudi Arabia. Journal of Family Medicine and Primary Care 2021; 10(8): 3005 doi: 10.4103/jfmpc.jfmpc_236_21
|
11 |
Afrin Kamal, Edgar Achkar, Dustin Carlson, John Clarke, Ronnie Fass, Chandra Prakash Gyawali, David A. Katzka, Dhyanesh Patel, Roberto Penagini, Ali Rezaie, Sabine Roman, Edoardo Savarino, Nicholas J. Shaheen, George Triadafilopoulos. Question Prompt List as a Communication Tool for Adults With Gastroesophageal Reflux Disease. Journal of Clinical Gastroenterology 2022; 56(7): 565 doi: 10.1097/MCG.0000000000001613
|
12 |
Ronnie Fass, Michael Vaezi, Prateek Sharma, Rena Yadlapati, Barbara Hunt, Tom Harris, Neila Smith, Eckhard Leifke, David Armstrong. Randomised clinical trial: Efficacy and safety of on‐demand vonoprazan versus placebo for non‐erosive reflux disease. Alimentary Pharmacology & Therapeutics 2023; 58(10): 1016 doi: 10.1111/apt.17728
|